Hepatitis C: Screening assays;Hepatite C: Outils du depistage

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 1 BIS, 1997, Pages

  Pham, Bach Nga ^a   Musset, Lucile ^b  

^a BEAUJON HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS ANTIBODY; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CONFERENCE PAPER; HEPATITIS C; HEPATITIS C VIRUS; SCREENING; SEROLOGY; VIRUS DETECTION; ANALYTICAL EQUIPMENT; HUMAN; INSTRUMENTATION; MASS SCREENING; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

HEPATITIS C; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0030984528     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (70)

1. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
2. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 1992;15:350-3.
3. Yuki N, Hayashi N, Hagiwara H, Takehara T, Oshita M, Kasahara A, et al. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay. J Hepatol 1993;17:170-4.
4. Alter HJ, Tegtmeier GE, Jett BW, Quan S, Shih JW, Bayer WL, et al. The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors. Transfusion 1991;31:771-6.
5. Ikeda Y, Toda G, Hashimoto N, Kurokawa K. Antibody to Superoxide dismutase, autoimmune hepatitis and antibody tests for hepatitis C virus. Lancet 1990;335:1345-6.
6. Theilmann L, Blazek M, Goeser T, Gmelin K, Kommerell B, Fiehn W. False-positive anti-HCV tests in rheumatoid arthritis. Lancet 1990;335:1346.
7. McFarlane IG, Smith HN, Johnson PJ, Gray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990;335:754-7.
8. Boudart D, Lucas JC, Muller JY, Le Carrier D, Planchon B, Harousseau JL. False-positive hepatitis C virus antibody tests in paraproteinaemia. Lancet 1990; 336:63.
9. Couroucé AM. Les trousses de dépistage des anticorps anti-VHC: résultats comparatifs. Rev Fr Transfus Hemobiol 1992;35:183-91.
10. Baath L, Widell A, Nordenfelt E. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction. J Viral Methods 1992;40:287-96.
11. McHutchison JG, Person JL, Govindarajan S, Valinluck B, Gore T, Lee SR, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992;15:19-25.
12. Aach RD, Stevens CE, Hollinger B, Mosley JW, Peterson DA, Taylor PE, et al. Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 1991;325:1325-9.
13. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
14. Esteban JI, Gonzalez A, Hemandez JM, Viladomiu L, Sanchez C, Lopez-Talavera JC, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-12.
15. Van der Poel CL, Bresters D, Reesink HW, Plaisier AAD, Schaasberg W, Leentvaar-Kuypers A, et al. Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang 1992;62:208-12.
16. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih W-K. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol 1992;30:552-6.
17. Giuberti T, Ferrari C, Marchelli S, Degli Antoni AM, Schianchi C, Pizzaferri P, et al. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute non-A, non-B hepatitis and different outcome of liver disease. Liver 1992;12:94-9.
18. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Kasahara A, et al. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors. Vox Sang 1994;67:280-5.
19. Di Maggie A, Annicchiarico R, De Siati M, Morangi A, Montemurro NE, Loperfido A, et al. Confirmation of high prevalence of hepatitis C antibodies in hemodialysis patients by second generation immunoblot assay. Nephron 1992;61:347-9.
20. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993;168:1343-8.
21. Couroucé AM, Le Marrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 1994;34:790-5.
22. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:122-9.
23. Lavanchy D, Mayerat C, Morel B, Schneider P, Zufferey C, Gonvers JJ, et al. Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen. J Clin Microbiol 1994;32:2272-5
24. Ebling F, Naukkarien R, Liikola J. Recombinant immunoblotting assay for hepatitis C virus as predictor of infectivity. Lancet 1990;335:982-3.
25. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991;337:317-9.
26. Chaudhary RK, MacLean C. Evaluation of first- and second-generation RIBA kits for detection of antibody of hepatitis C virus. J Clin Microbiol 1991;29:2329-30.
27. Polito AJ, Di Nello RK, Quan S, Andrews W, Rose J, Lee F, et al. New generation RIBA hepatitis C strip immunoblot assays. Ann Biol Clin 1992;50:329-36.
28. Dussaix E, Charnaux N, Laurent-Puig P, Chopineau S, Laurian Y, Buffet C. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody. J Clin Microbiol 1994;32:2071-5.
29. Rivanera D, Lorino G, Lilli D, Dicuonzo G, Mancini C. Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides. Eur J Epidemiol 1994;10:235-7.
30. Pawlotsky JM, Fleury A, Choukroun V, Deforges L, Roudot-Thoraval F, Aumont P. et al. Significance of highly positive c22-3 « indeterminate » second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol 1994;32.1357-9.
31. Zanella A, Conte D, Prati D, Mozzi F, Capelli C, Zanuso F, et al. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Hepatology 1995;21:913-7.
32. Alberti A. Diagnosis of hepatitis C. Facts and perspectives. J Hepatol 1991;12:279-82.
33. Puoti M, Zonaro A, Ravaggi A, Marin MG, Castelnuovo F, Cariani E. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology 1992;16:877-81.
34. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992;16:300-5.
35. Bresters D, Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Van Exel-Oehlers PJ, et al. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion 1993;33:634-8.
36. Buffet C, Charnaux N, Laurent-Puig P, Chopineau S, Quichon JP, Briantais MJ, et al. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay. J Med Virol 1994;43:259-61.
37. Sato S, Fujiyama S, Tanaka M, Goto M, Taura Y, Kawano SI, et al. IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection. Dig Dis Sci 1994;39:2022-31.
38. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Katayama K, et al. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers. J Hepatol 1994;21:110-4.
39. Tassopoulos NC, Hatzakis AE, Papatheodoridis GV, Karvountzis G, Troonen H, Lennartz L. Early prediction of successful apha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus. J Hepatol 1994;20:305-11.
40. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994;42:311-7.
41. Quiroga JA, Bosch O, Gonzalez R, Marriott E, Castillo I, Bartolome J, et al. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C. Gastroenterology 1992;103:1285-9.
42. Chen M, Sonnerborg A, Sallberg M. Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein. J Clin Microbiol 1995;33:778-80.
43. Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desai S, Johnson R, et al. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 1995;45:415-22.
44. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Mita E, Ohkawa K, et al. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology 1996;23:947-52.
45. Castillo I, Bartolome J, Quiroga JA, Carreno V. Comparison of several PCR procedures for detection of serum HCV-RNA using different regions of the HCV genome. J Virol Methods 1992;38:71-80.
46. Parvaz P, Guichard E, Chevallier P, Ritter J, Trépo C, Sépetjan M. Hepatitis C: description of a highly sensitive method for clinical detection of viral RNA J Virol Methods 1994;47:83-94.
47. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 1992;89:187-91.
48. McGuinness PH, Bishop GA, Lien A, Wiley B, Parsons C, McGaughan GW. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology 1993;18:485-90.
49. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992;89:4942-6.
50. Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis. Blood 1991;77:1157-60.
51. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-4.
52. French Study Group for the Standardization of Hepatitis C virus PCR. Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. J Virol Methods 1994;49:79-88.
53. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
54. Lunel F, Mariotti M, Cresta P, De La Croix I, Huraux JM, Lefrère JJ. Comparative study of conventional and novel strategies for the detection of hepatitis C virus RNA in serum: amplicor, branched-DNA, NASBA and in-house PCR. J Virol Methods 1995;54:159-71.
55. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996;34:901-7.
56. Mantero G, Zonaro A, Albertini A, Bertolo P, Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem 1991;37:422-9.
57. Ravaggi A, Zonaro A, Mazza C, Albertini A, Cariani E. Quantification of hepalitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates. J Clin Microbiol 1995;33.265-9.
58. Saldanha J, Minor P. Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang 1996;70:148-51.
59. Van Doorn LJ, Kleter B, Voermans J, Maertens G, Brouwer H, Heijtink R, et al. Rapid detection of hepatitis C virus RNA by direct capture from blood. J Med Virol 1994;42:22-8.
60. Hsuih TCH, Park YN, Zaretsky C, Wu F, Tyagi S., Russell-Kramer F, et al. Novel, ligation-dependent PCR assay for detection of hepatitis C virus in serum. J Clin Microbiol 1996;34:501-7.
61. Wang JT, Wang TH, Shcu JC, Lin SM, Lin JT, Chen DS. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992;30:750-3.
62. Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994;19:1337-41
63. Halfen P, Khiri H, Gérolami V, Bourlière M, Feryn JM, Reynier P, et al. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996;25:307-11.
64. Romeo JM, Ulrich PP, Busch MP, Vyas GN. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology 1993;17:188-95.
65. Van Thiel DH, Fagiuoli S, Caraceni P, Wright HI, Nadir A, Gavaler JS, et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995;22:464-7.
66. Dow BC, Follett EAC, Munro H, Buchanan I, Roy K, McOmish F, et al. Failure of 2nd- and 3rd-generation HCV ELISA and RIBA to detect HCV polymerase chain reaction-positive donations. Vox Sang 1994;67:236-7.
67. Sankary TM, Yang G, Romeo JM, Ulrich PP, Busch MP, Rawal BD, et al. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase. Transfusion 1994;34:656-60
68. Busch MP, Korelitz JJ, Kleinman SH, Lee SR, Aubuchon JP, Schreiber GB, and the Retrovirus Epidemiology Donor Study. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. Transfusion 1995;35:903-10.
69. Wolff C, Kleesiek K, Petersen N, Beyer J. Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening. Transfusion 1994;34:361-2.
70. Dubois F, François M, Mariette N, Caces E, Vol S, Romgeard P, et al. Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup. J Hepatol 1994;21:837-41.